NORTHERN DYNASTY MINERALS (NAK)       0.227  +0 (+0.89%)

0.227  +0 (+0.89%)

CA66510M2040 - Common Stock - After market: 0.2225 0 (-1.98%)


Fundamental Rating

3

Overall NAK gets a fundamental rating of 3 out of 10. We evaluated NAK against 981 industry peers in the Metals & Mining industry. NAK has a great financial health rating, but its profitability evaluates not so good. NAK is valued expensive and it does not seem to be growing.

Note: NAK has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating

1

NAK has a quite weak Piotroski-F score of 3.00. This indicates issues in the health and profitability of NAK.

VS Industry

Valuation

Valuation Rating

2

Compared to an average industry price book ratio of 1.69, NAK is valued rather cheaply
When comparing the current price to the book value of NAK, we can conclude it is valued correctly. It is trading at 1.01 times its book value.

The Price/Earnings Ratio is negative for NAK. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NAK. No positive earnings are expected for the next year.
VS Industry

Price/Book (1.01) VS Industry: 69% outperformed.

499.47
0.03

Growth

Growth Rating

3

The Earnings Per Share has grown by an impressive 66.67% over the past year.

NAK is expected to show a small growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 9.88% yearly.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A 66.67% 32.67% 28.97% 9.88% N/A
RevenueN/A N/A N/A N/A N/A N/A N/A

Health

Health Rating

7

NAK has a Current Ratio of 4.46. This indicates that NAK is financially healthy and has no problem in meeting its short term obligations.
NAK is better placed than average in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 2.63.
A Quick Ratio of 4.46 indicates that NAK has no problem at all paying its short term obligations.
NAK is better placed than average in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 2.24.

An Altman-Z score of 6.43 indicates that NAK is not in any danger for bankruptcy at the moment.
When comparing the Altman-Z score to an average industry score of 2.68, NAK is in better financial health than the average industry peer.
The Debt to Equity ratio of NAK is in line with the industry averages.
NAK has a quite weak Piotroski-F score of 3.00. This indicates issues in the health and profitability of NAK.
VS Industry

Debt/Equity (0) VS Industry: 41% outperformed.

4.83
0.00

Quick Ratio (4.46) VS Industry: 65% outperformed.

0.00
211.92

Current Ratio (4.46) VS Industry: 64% outperformed.

0.00
211.92

Altman-Z (6.43) VS Industry: 64% outperformed.

-22,403.48
2,115.39

Dividend

Dividend Rating

0

NAK does not give a dividend.

NORTHERN DYNASTY MINERALS0.227

NYSEARCA:NAK (2/3/2023, 7:04:00 PM)+0 (+0.89%)

After market: 0.2225 0 (-1.98%)

Chartmill FA Rating
GICS Sector Materials
GICS IndustryGroup Materials
GICS Industry Metals & Mining
Earnings (Last) 11-13 2022-11-13/amc Earnings (Next) 03-29 2023-03-29/amc
Inst Owners 12.39% Inst Owner Change -0.12%
Ins Owners N/A Ins Owner Change N/A
Market Cap 115.55M Analysts 80
Price Target 0.61 (168.72%)

Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y) N/A DP N/A
Div Incr Years N/A Div Non Decr Years N/A
Ex-Date N/A

Surprises & Revisions
EPS beat(2) N/A Avg EPS beat(2) N/A
Min EPS beat(2) N/A Max EPS beat(2) N/A
EPS beat(4) N/A Avg EPS beat(4) N/A
Min EPS beat(4) N/A Max EPS beat(4) N/A
Revenue beat(2) N/A Avg Revenue beat(2) N/A
Min Revenue beat(2) N/A Max Revenue beat(2) N/A
Revenue beat(4) N/A Avg Revenue beat(4) N/A
Min Revenue beat(4) N/A Max Revenue beat(4) N/A
PT rev (1m) 2.99% PT rev (3m) 4.7%
EPS NQ rev (1m) N/A EPS NQ rev (3m) 100%
EPS NY rev (1m) 0% EPS NY rev (3m) -33.33%
Revenue NQ rev (1m) N/A Revenue NQ rev (3m) N/A
Revenue NY rev (1m) N/A Revenue NY rev (3m) N/A

Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.01
P/tB 1.01
EV/EBITDA N/A
EPS(TTM) -0.02 EY N/A
EPS(NY) -0.02 Fwd EY N/A
FCF(TTM) -0.03 FCFY N/A
OCF(TTM) -0.03 OCFY N/A
SpS N/A BVpS 0.22
TBVpS 0.22 PEG (NY) N/A
PEG (5Y) N/A

Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM N/A
GM N/A
ROICexgc(3y) N/A ROICexcg growth 3Y N/A
ROICexcg growth 5Y N/A ROICexc(3y) N/A
ROICexc growth 3Y N/A ROICexc growth 5Y N/A
OM growth 3Y N/A OM growth 5Y N/A
PM growth 3Y N/A PM growth 5Y N/A
GM growth 3Y N/A GM growth 5Y N/A
F-Score 3 Asset Turnover N/A

Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Profit Quality N/A
Current Ratio 4.46
Quick Ratio 4.46
Altman-Z 6.43
F-Score 3 WACC N/A
ROIC/WACC N/A Cap/Depr(3y) N/A
Cap/Depr(5y) N/A Profit Quality(3y) N/A
Profit Quality(5y) N/A

Growth
EPS 1Y 66.67% EPS 3Y N/A
EPS 5Y N/A EPS growth Q2Q 50%
EPS Next Y 32.67% EPS Next 2Y 28.97%
EPS Next 3Y 9.88% EPS Next 5Y N/A
Revenue growth 1Y N/A Revenue growth 3Y N/A
Revenue growth 5Y N/A Revenue growth Q2Q N/A
Revenue Next Year N/A Revenue Next 2Y N/A
Revenue Next 3Y N/A Revenue Next 5Y N/A
EBIT growth 1Y 42.19% EBIT growth 3Y N/A
EBIT growth 5Y N/A EBIT Next Year 31.22%
EBIT Next 3Y 16.23% EBIT Next 5Y N/A
FCF growth 1Y 66.62% FCF growth 3Y N/A
FCF growth 5Y N/A OCF growth 1Y 66.66%
OCF growth 3Y N/A OCF growth 5Y N/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA